Clinic-Based Evaluation of A Point-Of-Care Creatinine Assay to Screen for Renal Impairment Amongst Hiv-Positive Patients Receiving Tenofovir Disoproxil Fumarate.

Dorward J, Yende-Zuma N, Samsunder N, Abdool Karim Q, Drain PK, Garrett N.
JAIDS 2018; 77(4):e36-e39. doi: 10.1097/QAI.0000000000001613.

Read publication
Acceptability of HIV Self-Testing in Sub-Saharan Africa: Scoping Study.

Harichund C, Moshabela M.
AIDS and Behavior 2018; 22(2):560-568.

Read publication
Neutralization tiers of HIV-1.

Montefiori DC, Roederer M, Morris L, Seaman MS.
Current Opinion in HIV and AIDS 2018; 13(2):128-136.

Read publication
HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies.

Serwanga J, Ssemwanga D, Muganga M, Nakiboneka R, Nakubulwa S, Kiwuwa-Muyingo S, Morris L, Redd AD, Quinn TC, Kaleebu P, HIV Superinfection Study Group.
Vaccine 2018; 36(4):578-586.

Read publication
Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.

Reh L, Magnus C, Kadelka C, Kühnert D, Uhr T, Weber J, Morris L, Moore PL, Trkola A.
PLoS pathogens 2018; 14(1):e1006825. doi: 10.1371/journal.ppat.1006825.

Read publication
HLA class I-mediated HIV-1 control in Vietnamese infected with HIV-1 subtype A/E.

Chikata T, Van Tran G, Murakoshi H, Akahoshi T, Qi Y, Naranbhai V, Kuse N, Tamura Y, Koyanagi M, Sakai S, Nguyen DH, Nguyen DT, Nguyen HT, Nguyen TV, Oka S, Martin MP, Carrington M, Sakai K, Van Nguyen K, Takiguchi M.
Journal of Viroloy 2018; 92(5). pii: e01749-17. doi: 10.1128/JVI.01749-17.

Read publication

Centre for the AIDS Programme of Research in South Africa

CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.